
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Cancer</journal-id><journal-id journal-id-type="iso-abbrev">J Cancer</journal-id><journal-id journal-id-type="publisher-id">jca</journal-id><journal-title-group><journal-title>Journal of Cancer</journal-title></journal-title-group><issn pub-type="epub">1837-9664</issn><publisher><publisher-name>Ivyspring International Publisher</publisher-name><publisher-loc>Sydney</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">32742500</article-id><article-id pub-id-type="pmc">7391207</article-id><article-id pub-id-type="doi">10.7150/jca.46563</article-id><article-id pub-id-type="publisher-id">jcav11p5527</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Paper</subject></subj-group></article-categories><title-group><article-title>A Predictive Nomogram for Early Death of Metastatic Gastric Cancer: A Retrospective Study in the SEER Database and China</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Zhu</surname><given-names>Ying</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Fang</surname><given-names>Xiongfeng</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Lanqing</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Tao</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="corresp" rid="FNA_envelop">&#x02709;</xref></contrib><contrib contrib-type="author"><name><surname>Yu</surname><given-names>Dandan</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="corresp" rid="FNA_envelop">&#x02709;</xref></contrib></contrib-group><aff id="A1"><label>1</label>Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.</aff><aff id="A2"><label>2</label>School of Electrical and Electronic Engineering, Huazhong University of Science and Technology, Wuhan 430074, China.</aff><author-notes><corresp id="FNA_envelop">&#x02709; Corresponding authors: Tao Zhang and Dandan Yu. Both authors make an equal contribution to this article.</corresp><fn fn-type="COI-statement"><p>Competing Interests: The authors have declared that no competing interest exists.</p></fn></author-notes><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>14</day><month>7</month><year>2020</year></pub-date><volume>11</volume><issue>18</issue><fpage>5527</fpage><lpage>5535</lpage><history><date date-type="received"><day>1</day><month>4</month><year>2020</year></date><date date-type="accepted"><day>5</day><month>7</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; The author(s)</copyright-statement><copyright-year>2020</copyright-year><license license-type="open-access"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>). See <ext-link ext-link-type="uri" xlink:href="http://ivyspring.com/terms">http://ivyspring.com/terms</ext-link> for full terms and conditions.</license-p></license></permissions><abstract><p><bold>Background:</bold> To identify associated risk factors and develop a predictive nomogram for the early death of metastatic gastric cancer patients.</p><p><bold>Methods:</bold> A total of 4575 patients in the SEER cohort and 220 patients in the Chinese cohort diagnosed with metastatic gastric cancer in our Cancer Center were obtained. Univariate and multivariate logistic regression models were used to identify independent risk variables for early death. A predictive nomogram and a web-based probability calculator were developed and then validated by receiver operating characteristics (ROCs) curve and calibration plot in a Chinese cohort.</p><p><bold>Results:</bold> Eight independent variables, including race, grade, surgery, chemotherapy, and metastases of bone, brain, liver, lung were recognized by using univariate and multivariate logistic regression models for identifying independent risk variables of early death about metastatic gastric cancer patients. By comprising these variables, a predictive nomogram and a web-based probability calculator were constructed in the SEER cohort. Then, it could be validated well in the Chinese cohort by receiver operating characteristics (ROCs) curve and calibration plot.</p><p><bold>Conclusion:</bold> Using this nomogram model provided an insightful and applicable tool to distinguish the early death of metastatic gastric cancer patients.</p></abstract><kwd-group><kwd>Stomach neoplasm</kwd><kwd>Stage IV</kwd><kwd>SEER</kwd><kwd>Early death</kwd><kwd>Nomogram</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Gastric cancer remains one of the most common malignancies all over the world, particularly in Asia <xref rid="B1" ref-type="bibr">1</xref>-<xref rid="B3" ref-type="bibr">3</xref>. Most patients are diagnosed with advanced stages on account of unspecific symptoms <xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B5" ref-type="bibr">5</xref>. There are still no curable treatments but only approved treatments like chemotherapy and immunotherapy for metastatic gastric cancer patients currently <xref rid="B6" ref-type="bibr">6</xref>. Though targeted drugs can prolong the survival time of metastatic patients, the median is approximately 11-16 months <xref rid="B7" ref-type="bibr">7</xref>. With the development of therapeutic approaches, metastatic gastric cancer patients have opportunities to survive better <xref rid="B8" ref-type="bibr">8</xref>. However, early death (survival time &#x02264;3 months) of metastatic gastric cancer patients remains unsolved problems <xref rid="B8" ref-type="bibr">8</xref>. Therefore, it's necessary to identify risk factors of early death in gastric cancer patients. Such studies had been reported in colorectal cancer and ovarian cancer, but the researches in gastric cancer were rarely reported <xref rid="B9" ref-type="bibr">9</xref>, <xref rid="B10" ref-type="bibr">10</xref>.</p><p>This study aimed to recognize risk factors and establish a predictive nomogram for the early death of metastatic gastric cancer patients based on a large population cohort and a Chinese cohort.</p></sec><sec sec-type="methods"><title>Materials and Methods</title><sec><title>Population</title><p>The SEER database, supported by the National Cancer Institute, constituted approximately 27.8% of the US population. SEER*Stat software (Version 8.3.6) was used to extract clinical information. We applied the primary site codes C16.0-C16.9 for gastric and the International Classification of Diseases for Oncology, Third Edition (ICD-O-3) histologic codes 8140/3 (Adenocarcinoma, NOS), 8211/3 (Tubular adenocarcinoma), 8260/3 (Papillary adenocarcinoma), 8480/3 (Mucinous adenocarcinoma), 8490/3 (Signet ring cell carcinoma) for adenocarcinoma. The information for metastatic sites of the bone (SEER Combined Mets at DX-bone), brain (SEER Combined Mets at DX-brain), liver (SEER Combined Mets at DX-liver), and lung (SEER Combined Mets at DX-lung) were collected since 2010, thus metastatic gastric cancer patients diagnosed stage IV and from 2010 to 2015 were included. Patients of metastatic gastric cancer without histological confirmation, only one primary malignancy, survival months, race, marital status, grade, and cause of death were excluded. Surgery was not recommended in metastatic gastric cancer; therefore T stage and N stage without specific information were accepted. Demographic and clinical characteristics were withdrawn in the SEER database as follows: age, sex, race, marital status, primary site, histology, grade, bone metastases, brain metastases, liver metastases, lung metastases, T stage, N stage, surgery, radiation, chemotherapy, cause of death, survival months.</p><p>The clinical data for metastatic gastric cancer patients initially diagnosed at Cancer Center, Union Hospital between January 2011 and September 2018 were collected retrospectively. The last follow-up was in January 2019. The inclusion and exclusion criteria mentioned above for the SEER cohort were also applied to the Chinese cohort. Surgery was not observed in the Chinese cohort and marital status was not recorded as well. T stage and N stage were mainly based on CT or endoscopic ultrasonography. Besides, smoking and drinking history were recorded. Death less than 3 months since the first diagnosis was regarded as early death in patients with malignant tumors.</p><p>This retrospective study of the Chinese cohort was approved by the ethics committee of Tongji Medical College, Huazhong University of Science and Technology in accordance with the ethical standards prescribed by the Helsinki Declaration.</p></sec><sec><title>Nomogram Development and Statistical analysis</title><p>Categorical data were described by the number and the percentage (N, %). Univariate and multivariate logistic regression models were utilized to identify variables that significantly associated with the early death of metastatic gastric cancer in the SEER sets. Then the predictive nomogram based on independent factors was constructed for the early death of metastatic gastric cancer by the SEER cohort. To evaluate the calibration and discrimination of the nomogram, an external independent Chinese patient validation cohort was used. For calibration, the nomogram predicted probabilities were contrasted with the actual probabilities by bootstrapping with 1000 resamples. The receiver operating characteristic (ROC) curve was used to judge discrimination. The higher the area under the curve (AUC) was, the better the accuracy would be. The &#x0201c;DynNom&#x0201d; and &#x0201c;shiny&#x0201d; packages were used to construct a web-based probability calculator, which could dynamically predict the probability of early death.</p><p>All analyses were performed using the R software (version 3.6.2). A two-tailed <italic>P</italic> value less than 0.01 was considered statistically significant.</p></sec></sec><sec sec-type="results"><title>Results</title><sec><title>Demographic and clinical characteristics</title><p>There were 4575 patients in the SEER database and 220 patients in our cancer center enrolled in this study. The demographic and clinical characteristics of metastatic gastric cancer were listed in Table <xref rid="T1" ref-type="table">1</xref>.</p><p>For the SEER cohort, most patients (82.4%) were between 40 to 79 years old. 65.3% of the patients are male and 61.3% are married. The main primary sites were gastric antrum and cardiac. The most common metastatic sites were liver, accounting for approximately 43.2% of liver metastases. Only 10.3% of patients performed surgery and 19.6% of patients performed radiation. There were nearly 67.6% of patients that received chemotherapy. The majority of metastatic gastric cancer patients died of the primary disease, while few of them died of other causes such as heart disease, cerebrovascular disease, septicemia, and so on.</p><p>In the Chinese cohort, the majority of patients (91.9%) were between 40 to 79 years old. The proportion of male patients was nearly equal to female patients. Approximately 20.9% and 20.0% of patients had a smoking history and drinking history, respectively. Metastatic gastric cancer patients constituted 32.3% of the liver metastases. Most patients (72.3%) received chemotherapy.</p></sec><sec><title>Identifying independent factors for early death</title><p>By applying univariate and multivariate logistic regression in the SEER cohort, the risk variables for the early death of metastatic gastric cancer were analyzed (Table <xref rid="T2" ref-type="table">2</xref>). Univariate logistic models showed that age, marital status, primary site, grade, metastases of bone, brain metastases, metastases of liver, lung metastases, T stage, N stage, surgery, radiation, and chemotherapy were associated with early death. Multivariate analyses proved eight independent risk factors including race, grade, surgery, chemotherapy, and metastases of bone, brain, liver, lung, which were significantly related to the early death of metastatic gastric cancer.</p></sec><sec><title>Nomogram construction</title><p>The predictive nomogram relying on identified risk factors from multivariate logistic regression models in the SEER cohort was constructed in Figure <xref ref-type="fig" rid="F1">1</xref>. By calculating every point of variables, the total number of points could be associated with the probability of early death of metastatic gastric cancer.</p></sec><sec><title>Nomogram validation</title><p>The predictive nomogram was validated both in the SEER cohort and the Chinese cohort. For the Chinese cohort, nomogram predicted probabilities of early death were computed according to the nomogram based on the SEER cohort. The calibration plots performed well both in the training and validation cohort (Figure <xref ref-type="fig" rid="F2">2</xref>C-D). Besides, applicable AUC was shown in both sets (Figure <xref ref-type="fig" rid="F2">2</xref>A-B).</p></sec><sec><title>Web-based probability calculator</title><p>According to the above results, a dynamic web-based probability calculator (https:/wandertheworld.shinyapps.io/DynNomapp/) was constructed to predict the early death of metastatic gastric cancer patients on the basis of the previous nomogram (Figure <xref ref-type="fig" rid="F3">3</xref>A). It's very convenient to individually predict the early death probability of patients based on their clinical characteristics. For instance, the early death probability of metastatic gastric cancer was approximately 27.9% (95% <italic>CI</italic>: 24.0-32.1%) for white patients with a poorly or differentiated grade, bone metastasis, chemotherapy, and without brain metastasis, liver metastasis, lung metastasis, surgery (Figure <xref ref-type="fig" rid="F3">3</xref>B).</p></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>The incidence and morbidity of gastric cancer remained high worldwide <xref rid="B11" ref-type="bibr">11</xref>. Thanks to the development of a number of treatments including targeted drugs, immunotherapy, and radiation, the median survival time had been prolonged all the time <xref rid="B12" ref-type="bibr">12</xref>-<xref rid="B16" ref-type="bibr">16</xref>. However, one-third and one-fifth of early death which was defined as death came up within 3 months occurred in the SEER cohort and the Chinese cohort of this study, respectively. Researchers concentrated deeply on associated independent variables of overall survival, cancer-specific survival, and noncancer-specific survival in gastric cancer <xref rid="B17" ref-type="bibr">17</xref>-<xref rid="B19" ref-type="bibr">19</xref>. And nomograms had been widely developed and used for predicting long-term survival of cancers <xref rid="B20" ref-type="bibr">20</xref>-<xref rid="B24" ref-type="bibr">24</xref>. To the best of our knowledge, this was the first study to identify the associated risk factors and structure an available nomogram for recognizing the early death of metastatic gastric cancer patients.</p><p>For the SEER cohort, multivariate analyses identified eight independent risk factors, including race, grade, surgery, chemotherapy, and metastases of bone, brain, liver, lung. Some previous studies had reported that grade, surgery, chemotherapy, and distant metastasis were significantly related to overall survival <xref rid="B25" ref-type="bibr">25</xref>, <xref rid="B26" ref-type="bibr">26</xref>. This study firstly confirmed that these risk factors were related to early death. Since some studies showed that metastatic gastric cancer patients performing surgical resection had a relatively poor prognosis, the surgery for metastatic gastric cancer patients remained controversial <xref rid="B27" ref-type="bibr">27</xref>. Furthermore, for those stage IV gastric cancer patients with synchronous liver metastasis, surgery had been reconsidered with the improvement of longer overall survival time <xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B29" ref-type="bibr">29</xref>.</p><p>There were apparent differences between the SEER cohort and the Chinese cohort. A lot of factors might result in the differences, including incidence, insurance, economic conditions, treatment strategy, religious beliefs, and so on.</p><p>A convenient nomogram containing identified independent factors was constructed for predicting early death of metastatic gastric cancer patients. Once they were distinguished, closer attention and better therapeutic strategies such as clinical trials might be given by oncologists.</p><p>There were several limitations to this study. First, risk factors associated with early death, including peritoneal metastasis, numbers of metastatic sites, performance status, and background diseases were absent. Second, the excluded missing data might result in selection bias. Third, though a Chinese cohort was used to validate the nomogram, a large prospective study was requisite.</p><p>All in all, a comprehensive nomogram integrating identified risk factors and a web-based probability calculator based on the nomogram were constructed to distinguish the early death of metastatic gastric cancer patients. The nomogram might help oncologists to make better therapeutic strategies such as clinical trials, and hospice management.</p></sec></body><back><ack><p>The authors would like to thank the SEER database for providing clinical information.</p><sec><title>Funding</title><p>This study was funded by the National Natural Science Foundation of China (No.81874061 and No.81872429); the National Key R&#x00026;D Program of China (2018YFC1313300).</p></sec></ack><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><name><surname>Thrift</surname><given-names>AP</given-names></name><name><surname>El-Serag</surname><given-names>HB</given-names></name><article-title>Burden of Gastric Cancer</article-title><source>Clin Gastroenterol Hepatol</source><year>2020</year><volume>18</volume><fpage>534</fpage><lpage>42</lpage>
<pub-id pub-id-type="pmid">31362118</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Zheng</surname><given-names>R</given-names></name><name><surname>Baade</surname><given-names>PD</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Zeng</surname><given-names>H</given-names></name><name><surname>Bray</surname><given-names>F</given-names></name><etal/><article-title>Cancer statistics in China, 2015</article-title><source>CA: a cancer journal for clinicians</source><year>2016</year><volume>66</volume><fpage>115</fpage><lpage>32</lpage>
<pub-id pub-id-type="pmid">26808342</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><name><surname>Rahman</surname><given-names>R</given-names></name><name><surname>Asombang</surname><given-names>AW</given-names></name><name><surname>Ibdah</surname><given-names>JA</given-names></name><article-title>Characteristics of gastric cancer in Asia</article-title><source>World J Gastroenterol</source><year>2014</year><volume>20</volume><fpage>4483</fpage><lpage>90</lpage>
<pub-id pub-id-type="pmid">24782601</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><name><surname>Humphrys</surname><given-names>E</given-names></name><name><surname>Walter</surname><given-names>FM</given-names></name><name><surname>Rubin</surname><given-names>G</given-names></name><name><surname>Emery</surname><given-names>JD</given-names></name><name><surname>Johnson</surname><given-names>M</given-names></name><name><surname>Richards</surname><given-names>A</given-names></name><etal/><article-title>Patient symptom experience prior to a diagnosis of oesophageal or gastric cancer: a multi-methods study</article-title><source>BJGP Open</source><year>2020</year><volume>4</volume><fpage>bjgpopen20X101001</fpage>
</element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><name><surname>Monti</surname><given-names>M</given-names></name><name><surname>Massa</surname><given-names>I</given-names></name><name><surname>Foca</surname><given-names>F</given-names></name><name><surname>Morgagni</surname><given-names>P</given-names></name><name><surname>Framarini</surname><given-names>M</given-names></name><name><surname>Passardi</surname><given-names>A</given-names></name><etal/><article-title>Retrospective analysis of gastric cancer management in a real-world setting: a single-institution experience</article-title><source>Tumori</source><year>2020</year><volume>106</volume><fpage>165</fpage><lpage>71</lpage>
<pub-id pub-id-type="pmid">32167020</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><name><surname>Chen</surname><given-names>L-T</given-names></name><name><surname>Satoh</surname><given-names>T</given-names></name><name><surname>Ryu</surname><given-names>M-H</given-names></name><name><surname>Chao</surname><given-names>Y</given-names></name><name><surname>Kato</surname><given-names>K</given-names></name><name><surname>Chung</surname><given-names>HC</given-names></name><etal/><article-title>A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data</article-title><source>Gastric cancer: official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association</source><year>2020</year><volume>23</volume><fpage>510</fpage><lpage>9</lpage>
</element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><name><surname>Bang</surname><given-names>Y-J</given-names></name><name><surname>Van Cutsem</surname><given-names>E</given-names></name><name><surname>Feyereislova</surname><given-names>A</given-names></name><name><surname>Chung</surname><given-names>HC</given-names></name><name><surname>Shen</surname><given-names>L</given-names></name><name><surname>Sawaki</surname><given-names>A</given-names></name><etal/><article-title>Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial</article-title><source>Lancet (London, England)</source><year>2010</year><volume>376</volume><fpage>687</fpage><lpage>97</lpage>
</element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>ST</given-names></name><name><surname>Kim</surname><given-names>K</given-names></name><name><surname>Lee</surname><given-names>H</given-names></name><name><surname>Kozarewa</surname><given-names>I</given-names></name><name><surname>Mortimer</surname><given-names>PGS</given-names></name><etal/><article-title>Tumor Genomic Profiling Guides Patients with Metastatic Gastric Cancer to Targeted Treatment: The VIKTORY Umbrella Trial</article-title><source>Cancer Discov</source><year>2019</year><volume>9</volume><fpage>1388</fpage><lpage>405</lpage>
<pub-id pub-id-type="pmid">31315834</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Mao</surname><given-names>M</given-names></name><name><surname>Xu</surname><given-names>G</given-names></name><name><surname>Lin</surname><given-names>F</given-names></name><name><surname>Sun</surname><given-names>P</given-names></name><name><surname>Baklaushev</surname><given-names>VP</given-names></name><etal/><article-title>The incidence, associated factors, and predictive nomogram for early death in stage IV colorectal cancer</article-title><source>Int J Colorectal Dis</source><year>2019</year><volume>34</volume><fpage>1189</fpage><lpage>201</lpage>
<pub-id pub-id-type="pmid">31089875</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><name><surname>Urban</surname><given-names>RR</given-names></name><name><surname>He</surname><given-names>H</given-names></name><name><surname>Alfonso</surname><given-names>R</given-names></name><name><surname>Hardesty</surname><given-names>MM</given-names></name><name><surname>Gray</surname><given-names>HJ</given-names></name><name><surname>Goff</surname><given-names>BA</given-names></name><article-title>Ovarian cancer outcomes: Predictors of early death</article-title><source>Gynecol Oncol</source><year>2016</year><volume>140</volume><fpage>474</fpage><lpage>80</lpage>
<pub-id pub-id-type="pmid">26743531</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><name><surname>Siegel</surname><given-names>RL</given-names></name><name><surname>Miller</surname><given-names>KD</given-names></name><name><surname>Jemal</surname><given-names>A</given-names></name><article-title>Cancer statistics, 2020</article-title><source>CA: a cancer journal for clinicians</source><year>2020</year><volume>70</volume><fpage>7</fpage><lpage>30</lpage>
<pub-id pub-id-type="pmid">31912902</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><name><surname>Karrit</surname><given-names>S</given-names></name><name><surname>Belaid</surname><given-names>I</given-names></name><name><surname>Ezzairi</surname><given-names>F</given-names></name><name><surname>El Ghali</surname><given-names>A</given-names></name><name><surname>Bedioui</surname><given-names>A</given-names></name><name><surname>Bouzid</surname><given-names>N</given-names></name><etal/><article-title>Management, outcome and prognostic factors of metastatic gastric cancer</article-title><source>Annals of oncology: official journal of the European Society for Medical Oncology</source><year>2018</year><volume>29</volume><issue>Suppl 5</issue><fpage>v21</fpage><lpage>v2</lpage>
</element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><name><surname>Sasaki</surname><given-names>A</given-names></name><name><surname>Nakamura</surname><given-names>Y</given-names></name><name><surname>Togashi</surname><given-names>Y</given-names></name><name><surname>Kuno</surname><given-names>H</given-names></name><name><surname>Hojo</surname><given-names>H</given-names></name><name><surname>Kageyama</surname><given-names>S</given-names></name><etal/><article-title>Enhanced tumor response to radiotherapy after PD-1 blockade in metastatic gastric cancer</article-title><source>Gastric cancer: official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association</source><year>2020</year><comment>[Epub ahead of print]</comment>
</element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><name><surname>Ishigami</surname><given-names>H</given-names></name><name><surname>Fujiwara</surname><given-names>Y</given-names></name><name><surname>Fukushima</surname><given-names>R</given-names></name><name><surname>Nashimoto</surname><given-names>A</given-names></name><name><surname>Yabusaki</surname><given-names>H</given-names></name><name><surname>Imano</surname><given-names>M</given-names></name><etal/><article-title>Phase III Trial Comparing Intraperitoneal and Intravenous Paclitaxel Plus S-1 Versus Cisplatin Plus S-1 in Patients With Gastric Cancer With Peritoneal Metastasis: PHOENIX-GC Trial</article-title><source>Journal of clinical oncology: official journal of the American Society of Clinical Oncology</source><year>2018</year><volume>36</volume><fpage>1922</fpage><lpage>9</lpage>
<pub-id pub-id-type="pmid">29746229</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><name><surname>Guimbaud</surname><given-names>R</given-names></name><name><surname>Louvet</surname><given-names>C</given-names></name><name><surname>Ries</surname><given-names>P</given-names></name><name><surname>Ychou</surname><given-names>M</given-names></name><name><surname>Maillard</surname><given-names>E</given-names></name><name><surname>Andr&#x000e9;</surname><given-names>T</given-names></name><etal/><article-title>Prospective, randomized, multicenter, phase III study of fluorouracil, leucovorin, and irinotecan versus epirubicin, cisplatin, and capecitabine in advanced gastric adenocarcinoma: a French intergroup (F&#x000e9;d&#x000e9;ration Francophone de Canc&#x000e9;rologie Digestive, F&#x000e9;d&#x000e9;ration Nationale des Centres de Lutte Contre le Cancer, and Groupe Coop&#x000e9;rateur Multidisciplinaire en Oncologie) study</article-title><source>Journal of clinical oncology: official journal of the American Society of Clinical Oncology</source><year>2014</year><volume>32</volume><fpage>3520</fpage><lpage>6</lpage>
<pub-id pub-id-type="pmid">25287828</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Qin</surname><given-names>S</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Xiong</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>C</given-names></name><name><surname>Bai</surname><given-names>Y</given-names></name><etal/><article-title>Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction</article-title><source>Journal of clinical oncology: official journal of the American Society of Clinical Oncology</source><year>2016</year><volume>34</volume><fpage>1448</fpage><lpage>54</lpage>
<pub-id pub-id-type="pmid">26884585</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><name><surname>Park</surname><given-names>HS</given-names></name><name><surname>Kwon</surname><given-names>WS</given-names></name><name><surname>Park</surname><given-names>S</given-names></name><name><surname>Jo</surname><given-names>E</given-names></name><name><surname>Lim</surname><given-names>SJ</given-names></name><name><surname>Lee</surname><given-names>C-K</given-names></name><etal/><article-title>Comprehensive immune profiling and immune-monitoring using body fluid of patients with metastatic gastric cancer</article-title><source>J Immunother Cancer</source><year>2019</year><volume>7</volume><fpage>268</fpage>
<pub-id pub-id-type="pmid">31639056</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Sun</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Yan</surname><given-names>J</given-names></name><etal/><article-title>Prognostic significance of PD-L1 expression on cell-surface vimentin-positive circulating tumor cells in gastric cancer patients</article-title><source>Mol Oncol</source><year>2020</year><volume>14</volume><fpage>865</fpage><lpage>81</lpage>
<pub-id pub-id-type="pmid">31981446</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><name><surname>Oh</surname><given-names>C-M</given-names></name><name><surname>Lee</surname><given-names>D</given-names></name><name><surname>Kong</surname><given-names>H-J</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Won</surname><given-names>Y-J</given-names></name><name><surname>Jung</surname><given-names>K-W</given-names></name><etal/><article-title>Causes of death among cancer patients in the era of cancer survivorship in Korea: Attention to the suicide and cardiovascular mortality</article-title><source>Cancer Med</source><year>2020</year><volume>9</volume><fpage>1741</fpage><lpage>52</lpage>
<pub-id pub-id-type="pmid">31960609</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Geng</surname><given-names>Q</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Guo</surname><given-names>J</given-names></name><name><surname>Kong</surname><given-names>P</given-names></name><etal/><article-title>Development and external validation of a prognostic nomogram for gastric cancer using the national cancer registry</article-title><source>Oncotarget</source><year>2016</year><volume>7</volume><fpage>35853</fpage><lpage>64</lpage>
<pub-id pub-id-type="pmid">27016409</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><name><surname>Chen</surname><given-names>D</given-names></name><name><surname>Jiang</surname><given-names>B</given-names></name><name><surname>Xing</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Cui</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><etal/><article-title>Validation of the memorial Sloan-Kettering Cancer Center nomogram to predict disease-specific survival after R0 resection in a Chinese gastric cancer population</article-title><source>PLoS ONE</source><year>2013</year><volume>8</volume><fpage>e76041</fpage>
<pub-id pub-id-type="pmid">24146811</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><name><surname>Zhao</surname><given-names>R</given-names></name><name><surname>Jia</surname><given-names>T</given-names></name><name><surname>Qiao</surname><given-names>B</given-names></name><name><surname>Liang</surname><given-names>J</given-names></name><name><surname>Qu</surname><given-names>S</given-names></name><name><surname>Zhu</surname><given-names>L</given-names></name><etal/><article-title>Nomogram predicting long-term overall survival and cancer-specific survival of lip carcinoma patients based on the SEER database: A retrospective case-control study</article-title><source>Medicine</source><year>2019</year><volume>98</volume><fpage>e16727</fpage>
<pub-id pub-id-type="pmid">31415366</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><name><surname>Cao</surname><given-names>L-L</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Lin</surname><given-names>J-X</given-names></name><name><surname>Zheng</surname><given-names>C-H</given-names></name><name><surname>Li</surname><given-names>P</given-names></name><name><surname>Xie</surname><given-names>J-W</given-names></name><etal/><article-title>Incidence and survival trends for gastric neuroendocrine neoplasms: An analysis of 3523 patients in the SEER database</article-title><source>European journal of surgical oncology: the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology</source><year>2018</year><volume>44</volume><fpage>1628</fpage><lpage>33</lpage>
</element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Lin</surname><given-names>R-M</given-names></name><name><surname>Bai</surname><given-names>Y-K</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><article-title>Establishment and Verification of Prognostic Nomograms for Patients with Gastrointestinal Stromal Tumors: A SEER-Based Study</article-title><source>Biomed Res Int</source><year>2019</year><volume>2019</volume><fpage>8293261</fpage>
<pub-id pub-id-type="pmid">31032364</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><name><surname>Kawahara</surname><given-names>K</given-names></name><name><surname>Makino</surname><given-names>H</given-names></name><name><surname>Kametaka</surname><given-names>H</given-names></name><name><surname>Hoshino</surname><given-names>I</given-names></name><name><surname>Fukada</surname><given-names>T</given-names></name><name><surname>Seike</surname><given-names>K</given-names></name><etal/><article-title>Outcomes of surgical resection for gastric cancer liver metastases: a retrospective analysis</article-title><source>World J Surg Oncol</source><year>2020</year><volume>18</volume><fpage>41</fpage>
<pub-id pub-id-type="pmid">32093729</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><name><surname>Mikami</surname><given-names>J</given-names></name><name><surname>Kimura</surname><given-names>Y</given-names></name><name><surname>Makari</surname><given-names>Y</given-names></name><name><surname>Fujita</surname><given-names>J</given-names></name><name><surname>Kishimoto</surname><given-names>T</given-names></name><name><surname>Sawada</surname><given-names>G</given-names></name><etal/><article-title>Clinical outcomes and prognostic factors for gastric cancer patients with bone metastasis</article-title><source>World J Surg Oncol</source><year>2017</year><volume>15</volume><fpage>8</fpage>
<pub-id pub-id-type="pmid">28061855</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><name><surname>Fujitani</surname><given-names>K</given-names></name><name><surname>Yang</surname><given-names>H-K</given-names></name><name><surname>Mizusawa</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>Y-W</given-names></name><name><surname>Terashima</surname><given-names>M</given-names></name><name><surname>Han</surname><given-names>S-U</given-names></name><etal/><article-title>Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial</article-title><source>The Lancet Oncology</source><year>2016</year><volume>17</volume><fpage>309</fpage><lpage>18</lpage>
<pub-id pub-id-type="pmid">26822397</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><name><surname>Kodera</surname><given-names>Y</given-names></name><name><surname>Fujitani</surname><given-names>K</given-names></name><name><surname>Fukushima</surname><given-names>N</given-names></name><name><surname>Ito</surname><given-names>S</given-names></name><name><surname>Muro</surname><given-names>K</given-names></name><name><surname>Ohashi</surname><given-names>N</given-names></name><etal/><article-title>Surgical resection of hepatic metastasis from gastric cancer: a review and new recommendation in the Japanese gastric cancer treatment guidelines</article-title><source>Gastric cancer: official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association</source><year>2014</year><volume>17</volume><fpage>206</fpage><lpage>12</lpage>
</element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><name><surname>Picado</surname><given-names>O</given-names></name><name><surname>Dygert</surname><given-names>L</given-names></name><name><surname>Macedo</surname><given-names>FI</given-names></name><name><surname>Franceschi</surname><given-names>D</given-names></name><name><surname>Sleeman</surname><given-names>D</given-names></name><name><surname>Livingstone</surname><given-names>AS</given-names></name><etal/><article-title>The Role of Surgical Resection for Stage IV Gastric Cancer With Synchronous Hepatic Metastasis</article-title><source>The Journal of surgical research</source><year>2018</year><volume>232</volume><fpage>422</fpage><lpage>9</lpage>
<pub-id pub-id-type="pmid">30463751</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Figure 1</label><caption><p>The predictive nomogram for the early death of metastatic gastric cancer patients in the SEER database.</p></caption><graphic xlink:href="jcav11p5527g001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><p>ROC curves and calibration plots for the nomogram. (A) The ROC curve for the nomogram in the SEER cohort; (B) the ROC curve for the nomogram in the Chinese cohort; (C) the calibration plots for the nomogram in the SEER cohort; (D) the calibration plots for the nomogram in the Chinese cohort.</p></caption><graphic xlink:href="jcav11p5527g002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><p>A web-based probability calculator. White patients with a poorly or differentiated grade, bone metastasis, chemotherapy and without brain metastasis, liver metastasis, lung metastasis, surgery showed in the web probability calculator. (A) The graphical summary showed a rough range. (B) Numerical Summary showed the early death probability and its 95% confidence interval.</p></caption><graphic xlink:href="jcav11p5527g003"/></fig><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Demographic and clinical characteristics in the SEER database and Chinese cohort</p></caption><table frame="hsides" rules="groups"><thead valign="top"><tr><th rowspan="2" colspan="1">Characteristic</th><th colspan="5" rowspan="1">SEER cohort</th><th colspan="5" rowspan="1">Chinese cohort</th></tr><tr><th rowspan="1" colspan="1">Total death n=4575 (%)</th><th rowspan="1" colspan="1">Died 1-90 days, n=1647 (%)</th><th rowspan="1" colspan="1">Died 91-180 days,<break/>n=863 (%)</th><th rowspan="1" colspan="1">Died 181-360 days,<break/>n=1075 (%)</th><th rowspan="1" colspan="1">Died &#x0003e;1-year, n=990 (%)</th><th rowspan="1" colspan="1">Total death n=220 (%)</th><th rowspan="1" colspan="1">Died 1-90 days, n=45 (%)</th><th rowspan="1" colspan="1">Died 91-180 days, n=48 (%)</th><th rowspan="1" colspan="1">Died 181-360 days, n=70 (%)</th><th rowspan="1" colspan="1">Died &#x0003e;1-year, n=57 (%)</th></tr></thead><tbody valign="top"><tr><td rowspan="1" colspan="1"><bold>Age (years)</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x0003c;40</td><td rowspan="1" colspan="1">261 (5.7)</td><td rowspan="1" colspan="1">72 (4.4)</td><td rowspan="1" colspan="1">56 (6.5)</td><td rowspan="1" colspan="1">79 (7.3)</td><td rowspan="1" colspan="1">54 (5.5)</td><td rowspan="1" colspan="1">17 (7.7)</td><td rowspan="1" colspan="1">5 (11.1)</td><td rowspan="1" colspan="1">1 (2.1)</td><td rowspan="1" colspan="1">3 (4.3)</td><td rowspan="1" colspan="1">8 (14.0)</td></tr><tr><td rowspan="1" colspan="1">40-59</td><td rowspan="1" colspan="1">1581 (34.6)</td><td rowspan="1" colspan="1">463 (28.1)</td><td rowspan="1" colspan="1">313 (36.3)</td><td rowspan="1" colspan="1">411 (38.2)</td><td rowspan="1" colspan="1">394 (39.8)</td><td rowspan="1" colspan="1">100 (45.5)</td><td rowspan="1" colspan="1">17 (37.8)</td><td rowspan="1" colspan="1">27 (56.3)</td><td rowspan="1" colspan="1">35 (50.0)</td><td rowspan="1" colspan="1">21 (36.8)</td></tr><tr><td rowspan="1" colspan="1">60-79</td><td rowspan="1" colspan="1">2185 (47.8)</td><td rowspan="1" colspan="1">799 (48.5)</td><td rowspan="1" colspan="1">387 (44.8)</td><td rowspan="1" colspan="1">517 (48.1)</td><td rowspan="1" colspan="1">482 (48.7)</td><td rowspan="1" colspan="1">102 (46.4)</td><td rowspan="1" colspan="1">23 (51.1)</td><td rowspan="1" colspan="1">20 (41.7)</td><td rowspan="1" colspan="1">31 (44.3)</td><td rowspan="1" colspan="1">28 (49.1)</td></tr><tr><td rowspan="1" colspan="1">80+</td><td rowspan="1" colspan="1">548 (12.0)</td><td rowspan="1" colspan="1">313 (19.0)</td><td rowspan="1" colspan="1">107 (12.4)</td><td rowspan="1" colspan="1">68 (6.3)</td><td rowspan="1" colspan="1">60 (6.1)</td><td rowspan="1" colspan="1">1 (0.5)</td><td rowspan="1" colspan="1">0 (0.0)</td><td rowspan="1" colspan="1">0 (0.0)</td><td rowspan="1" colspan="1">1 (1.4)</td><td rowspan="1" colspan="1">0 (0.0)</td></tr><tr><td rowspan="1" colspan="1"><bold>Sex</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Male</td><td rowspan="1" colspan="1">2986 (65.3)</td><td rowspan="1" colspan="1">1070 (65.0)</td><td rowspan="1" colspan="1">560 (64.9)</td><td rowspan="1" colspan="1">700 (65.1)</td><td rowspan="1" colspan="1">656 (66.3)</td><td rowspan="1" colspan="1">113 (51.4)</td><td rowspan="1" colspan="1">22 (48.9)</td><td rowspan="1" colspan="1">20 (41.7)</td><td rowspan="1" colspan="1">38 (54.3)</td><td rowspan="1" colspan="1">33 (57.9)</td></tr><tr><td rowspan="1" colspan="1">Female</td><td rowspan="1" colspan="1">1589 (34.7)</td><td rowspan="1" colspan="1">577 (35.0)</td><td rowspan="1" colspan="1">303 (35.1)</td><td rowspan="1" colspan="1">375 (34.9)</td><td rowspan="1" colspan="1">334 (33.7)</td><td rowspan="1" colspan="1">107 (48.6)</td><td rowspan="1" colspan="1">23 (51.1)</td><td rowspan="1" colspan="1">28 (58.3)</td><td rowspan="1" colspan="1">32 (45.7)</td><td rowspan="1" colspan="1">24 (42.1)</td></tr><tr><td rowspan="1" colspan="1"><bold>Race</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">White</td><td rowspan="1" colspan="1">3384 (74.0)</td><td rowspan="1" colspan="1">1229 (74.6)</td><td rowspan="1" colspan="1">622 (72.1)</td><td rowspan="1" colspan="1">807 (75.1)</td><td rowspan="1" colspan="1">726 (73.3)</td><td rowspan="1" colspan="1">0 (0.0)</td><td rowspan="1" colspan="1">0 (0.0)</td><td rowspan="1" colspan="1">0 (0.0)</td><td rowspan="1" colspan="1">0 (0.0)</td><td rowspan="1" colspan="1">0 (0.0)</td></tr><tr><td rowspan="1" colspan="1">Black</td><td rowspan="1" colspan="1">558 (12.2)</td><td rowspan="1" colspan="1">214 (13.0)</td><td rowspan="1" colspan="1">98 (11.4)</td><td rowspan="1" colspan="1">122 (11.3)</td><td rowspan="1" colspan="1">124 (12.5)</td><td rowspan="1" colspan="1">0 (0.0)</td><td rowspan="1" colspan="1">0 (0.0)</td><td rowspan="1" colspan="1">0 (0.0)</td><td rowspan="1" colspan="1">0 (0.0)</td><td rowspan="1" colspan="1">0 (0.0)</td></tr><tr><td rowspan="1" colspan="1">Others</td><td rowspan="1" colspan="1">633 (13.8)</td><td rowspan="1" colspan="1">204 (12.4)</td><td rowspan="1" colspan="1">143 (16.6)</td><td rowspan="1" colspan="1">146 (13.6)</td><td rowspan="1" colspan="1">140 (14.1)</td><td rowspan="1" colspan="1">220 (100.0)</td><td rowspan="1" colspan="1">45 (100.0)</td><td rowspan="1" colspan="1">48 (100.0)</td><td rowspan="1" colspan="1">70 (100.0)</td><td rowspan="1" colspan="1">57 (100.0)</td></tr><tr><td rowspan="1" colspan="1"><bold>Marital status</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Married</td><td rowspan="1" colspan="1">2806 (61.3)</td><td rowspan="1" colspan="1">896 (54.4)</td><td rowspan="1" colspan="1">538 (62.3)</td><td rowspan="1" colspan="1">715 (66.5)</td><td rowspan="1" colspan="1">657 (66.4)</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td></tr><tr><td rowspan="1" colspan="1">Separated/Divorced</td><td rowspan="1" colspan="1">489 (10.7)</td><td rowspan="1" colspan="1">188 (11.4)</td><td rowspan="1" colspan="1">88 (10.2)</td><td rowspan="1" colspan="1">108 (10.0)</td><td rowspan="1" colspan="1">105 (10.6)</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td></tr><tr><td rowspan="1" colspan="1">Widowed</td><td rowspan="1" colspan="1">472 (10.3)</td><td rowspan="1" colspan="1">242 (14.7)</td><td rowspan="1" colspan="1">89 (10.3)</td><td rowspan="1" colspan="1">76 (7.1)</td><td rowspan="1" colspan="1">65 (6.6)</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td></tr><tr><td rowspan="1" colspan="1">Single</td><td rowspan="1" colspan="1">808 (17.7)</td><td rowspan="1" colspan="1">321 (19.5)</td><td rowspan="1" colspan="1">148 (17.1)</td><td rowspan="1" colspan="1">176 (16.4)</td><td rowspan="1" colspan="1">163 (16.5)</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td></tr><tr><td rowspan="1" colspan="1"><bold>Smoking history</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">46 (20.9)</td><td rowspan="1" colspan="1">11 (24.4)</td><td rowspan="1" colspan="1">10 (20.8)</td><td rowspan="1" colspan="1">13 (18.6)</td><td rowspan="1" colspan="1">12 (21.1)</td></tr><tr><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">174 (79.1)</td><td rowspan="1" colspan="1">34 (75.6)</td><td rowspan="1" colspan="1">38 (79.2)</td><td rowspan="1" colspan="1">57 (81.4)</td><td rowspan="1" colspan="1">45 (78.9)</td></tr><tr><td rowspan="1" colspan="1"><bold>Drinking history</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">44 (20.0)</td><td rowspan="1" colspan="1">8 (17.8)</td><td rowspan="1" colspan="1">10 (20.8)</td><td rowspan="1" colspan="1">16 (22.9)</td><td rowspan="1" colspan="1">10 (17.5)</td></tr><tr><td rowspan="1" colspan="1">No</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">176 (80.0)</td><td rowspan="1" colspan="1">37 (82.2)</td><td rowspan="1" colspan="1">38 (79.2)</td><td rowspan="1" colspan="1">54 (77.1)</td><td rowspan="1" colspan="1">47 (82.5)</td></tr><tr><td rowspan="1" colspan="1"><bold>Primary site</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Cardiac/fundus</td><td rowspan="1" colspan="1">1907 (41.7)</td><td rowspan="1" colspan="1">626 (38.0)</td><td rowspan="1" colspan="1">353 (40.9)</td><td rowspan="1" colspan="1">469 (43.6)</td><td rowspan="1" colspan="1">459 (46.4)</td><td rowspan="1" colspan="1">52 (23.6)</td><td rowspan="1" colspan="1">6 (13.3)</td><td rowspan="1" colspan="1">10 (20.8)</td><td rowspan="1" colspan="1">23 (32.9)</td><td rowspan="1" colspan="1">13 (22.8)</td></tr><tr><td rowspan="1" colspan="1">Body</td><td rowspan="1" colspan="1">451 (9.9)</td><td rowspan="1" colspan="1">158 (9.6)</td><td rowspan="1" colspan="1">98 (11.4)</td><td rowspan="1" colspan="1">110 (10.2)</td><td rowspan="1" colspan="1">85 (8.6)</td><td rowspan="1" colspan="1">55 (25.0)</td><td rowspan="1" colspan="1">17 (37.8)</td><td rowspan="1" colspan="1">12 (25.0)</td><td rowspan="1" colspan="1">15 (21.4)</td><td rowspan="1" colspan="1">11 (19.3)</td></tr><tr><td rowspan="1" colspan="1">Antrum/pylorus</td><td rowspan="1" colspan="1">690 (15.1)</td><td rowspan="1" colspan="1">269 (16.3)</td><td rowspan="1" colspan="1">113 (13.1)</td><td rowspan="1" colspan="1">156 (14.5)</td><td rowspan="1" colspan="1">154 (15.6)</td><td rowspan="1" colspan="1">60 (27.3)</td><td rowspan="1" colspan="1">14 (31.1)</td><td rowspan="1" colspan="1">8 (16.7)</td><td rowspan="1" colspan="1">17 (24.3)</td><td rowspan="1" colspan="1">21 (36.8)</td></tr><tr><td rowspan="1" colspan="1">Lesser/greater curvature</td><td rowspan="1" colspan="1">846 (18.5)</td><td rowspan="1" colspan="1">140 (8.5)</td><td rowspan="1" colspan="1">79 (9.2)</td><td rowspan="1" colspan="1">100 (9.3)</td><td rowspan="1" colspan="1">82 (8.3)</td><td rowspan="1" colspan="1">2 (0.9)</td><td rowspan="1" colspan="1">1 (2.2)</td><td rowspan="1" colspan="1">1 (2.1)</td><td rowspan="1" colspan="1">0 (0.0)</td><td rowspan="1" colspan="1">0 (0.0)</td></tr><tr><td rowspan="1" colspan="1">Other</td><td rowspan="1" colspan="1">681 (14.9)</td><td rowspan="1" colspan="1">454 (27.6)</td><td rowspan="1" colspan="1">220 (25.5)</td><td rowspan="1" colspan="1">243 (22.6)</td><td rowspan="1" colspan="1">210 (21.1)</td><td rowspan="1" colspan="1">51 (23.2)</td><td rowspan="1" colspan="1">7 (15.6)</td><td rowspan="1" colspan="1">17 (35.4)</td><td rowspan="1" colspan="1">15 (21.4)</td><td rowspan="1" colspan="1">12 (21.1)</td></tr><tr><td rowspan="1" colspan="1"><bold>Histology</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Adenocarcinoma</td><td rowspan="1" colspan="1">3358 (73.4)</td><td rowspan="1" colspan="1">1232 (74.8)</td><td rowspan="1" colspan="1">626 (72.5)</td><td rowspan="1" colspan="1">767 (71.3)</td><td rowspan="1" colspan="1">733 (74.0)</td><td rowspan="1" colspan="1">182 (82.7)</td><td rowspan="1" colspan="1">37 (82.2)</td><td rowspan="1" colspan="1">41 (85.4)</td><td rowspan="1" colspan="1">59 (84.3)</td><td rowspan="1" colspan="1">45 (78.9)</td></tr><tr><td rowspan="1" colspan="1">Signet ring cell carcinoma</td><td rowspan="1" colspan="1">1217 (26.6)</td><td rowspan="1" colspan="1">415 (25.2)</td><td rowspan="1" colspan="1">237 (27.5)</td><td rowspan="1" colspan="1">308 (28.7)</td><td rowspan="1" colspan="1">257 (26.0)</td><td rowspan="1" colspan="1">38 (17.3)</td><td rowspan="1" colspan="1">8 (17.8)</td><td rowspan="1" colspan="1">7 (14.6)</td><td rowspan="1" colspan="1">11 (15.7)</td><td rowspan="1" colspan="1">12 (21.1)</td></tr><tr><td rowspan="1" colspan="1"><bold>Grade</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Well/moderately</td><td rowspan="1" colspan="1">1101 (24.1)</td><td rowspan="1" colspan="1">344 (20.9)</td><td rowspan="1" colspan="1">194 (22.5)</td><td rowspan="1" colspan="1">276 (25.7)</td><td rowspan="1" colspan="1">287 (29.0)</td><td rowspan="1" colspan="1">182 (82.7)</td><td rowspan="1" colspan="1">37 (82.2)</td><td rowspan="1" colspan="1">41 (85.4)</td><td rowspan="1" colspan="1">59 (84.3)</td><td rowspan="1" colspan="1">45 (78.9)</td></tr><tr><td rowspan="1" colspan="1">Poorly /undifferentiated</td><td rowspan="1" colspan="1">3474 (75.9)</td><td rowspan="1" colspan="1">1303 (79.1)</td><td rowspan="1" colspan="1">669 (77.5)</td><td rowspan="1" colspan="1">799 (74.3)</td><td rowspan="1" colspan="1">703 (71.0)</td><td rowspan="1" colspan="1">38 (17.3)</td><td rowspan="1" colspan="1">8 (17.8)</td><td rowspan="1" colspan="1">7 (14.6)</td><td rowspan="1" colspan="1">11 (15.7)</td><td rowspan="1" colspan="1">12 (21.1)</td></tr><tr><td rowspan="1" colspan="1"><bold>Bone metastases</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">607 (13.3)</td><td rowspan="1" colspan="1">254 (15.4)</td><td rowspan="1" colspan="1">122 (14.1)</td><td rowspan="1" colspan="1">146 (13.6)</td><td rowspan="1" colspan="1">85 (8.6)</td><td rowspan="1" colspan="1">24 (10.9)</td><td rowspan="1" colspan="1">4 (8.9)</td><td rowspan="1" colspan="1">8 (16.7)</td><td rowspan="1" colspan="1">6 (8.6)</td><td rowspan="1" colspan="1">6 (10.5)</td></tr><tr><td rowspan="1" colspan="1">No/unknown</td><td rowspan="1" colspan="1">3968 (86.7)</td><td rowspan="1" colspan="1">1393 (84.6)</td><td rowspan="1" colspan="1">741 (85.9)</td><td rowspan="1" colspan="1">929 (86.4)</td><td rowspan="1" colspan="1">905 (91.4)</td><td rowspan="1" colspan="1">196 (89.1)</td><td rowspan="1" colspan="1">41 (91.1)</td><td rowspan="1" colspan="1">40 (83.3)</td><td rowspan="1" colspan="1">64 (91.4)</td><td rowspan="1" colspan="1">51 (89.5)</td></tr><tr><td rowspan="1" colspan="1"><bold>Brain metastases</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">95 (2.1)</td><td rowspan="1" colspan="1">55 (3.3)</td><td rowspan="1" colspan="1">17 (2.0)</td><td rowspan="1" colspan="1">9 (0.8)</td><td rowspan="1" colspan="1">14 (1.4)</td><td rowspan="1" colspan="1">2 (0.9)</td><td rowspan="1" colspan="1">0 (0.0)</td><td rowspan="1" colspan="1">1 (2.1)</td><td rowspan="1" colspan="1">1 (1.4)</td><td rowspan="1" colspan="1">0 (0.0)</td></tr><tr><td rowspan="1" colspan="1">No/unknown</td><td rowspan="1" colspan="1">4480 (97.9)</td><td rowspan="1" colspan="1">1592 (96.7)</td><td rowspan="1" colspan="1">846 (98.0)</td><td rowspan="1" colspan="1">1066 (99.2)</td><td rowspan="1" colspan="1">976 (98.6)</td><td rowspan="1" colspan="1">218 (99.1)</td><td rowspan="1" colspan="1">45 (100.0)</td><td rowspan="1" colspan="1">47 (97.9)</td><td rowspan="1" colspan="1">69 (98.6)</td><td rowspan="1" colspan="1">57 (100.0)</td></tr><tr><td rowspan="1" colspan="1"><bold>Liver metastases</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">1975 (43.2)</td><td rowspan="1" colspan="1">764 (46.4)</td><td rowspan="1" colspan="1">366 (42.4)</td><td rowspan="1" colspan="1">453 (42.1)</td><td rowspan="1" colspan="1">392 (39.6)</td><td rowspan="1" colspan="1">71 (32.3)</td><td rowspan="1" colspan="1">18 (40.0)</td><td rowspan="1" colspan="1">15 (31.3)</td><td rowspan="1" colspan="1">20 (28.6)</td><td rowspan="1" colspan="1">18 (31.6)</td></tr><tr><td rowspan="1" colspan="1">No/unknown</td><td rowspan="1" colspan="1">2600 (56.8)</td><td rowspan="1" colspan="1">883 (53.6)</td><td rowspan="1" colspan="1">497 (57.6)</td><td rowspan="1" colspan="1">622 (57.9)</td><td rowspan="1" colspan="1">598 (60.4)</td><td rowspan="1" colspan="1">149 (67.7)</td><td rowspan="1" colspan="1">27 (60.0)</td><td rowspan="1" colspan="1">33 (68.8)</td><td rowspan="1" colspan="1">50 (71.4)</td><td rowspan="1" colspan="1">39 (68.4)</td></tr><tr><td rowspan="1" colspan="1"><bold>Lung metastases</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">656 (14.3)</td><td rowspan="1" colspan="1">275 (16.7)</td><td rowspan="1" colspan="1">127 (14.7)</td><td rowspan="1" colspan="1">145 (13.5)</td><td rowspan="1" colspan="1">109 (11.0)</td><td rowspan="1" colspan="1">14 (6.4)</td><td rowspan="1" colspan="1">1 (2.2)</td><td rowspan="1" colspan="1">4 (8.3)</td><td rowspan="1" colspan="1">5 (7.1)</td><td rowspan="1" colspan="1">4 (7.0)</td></tr><tr><td rowspan="1" colspan="1">No/unknown</td><td rowspan="1" colspan="1">3919 (85.7)</td><td rowspan="1" colspan="1">1372 (83.3)</td><td rowspan="1" colspan="1">736 (85.3)</td><td rowspan="1" colspan="1">930 (86.5)</td><td rowspan="1" colspan="1">881 (89.0)</td><td rowspan="1" colspan="1">206 (93.6)</td><td rowspan="1" colspan="1">44 (97.8)</td><td rowspan="1" colspan="1">44 (81.7)</td><td rowspan="1" colspan="1">65 (92.9)</td><td rowspan="1" colspan="1">53 (93.0)</td></tr><tr><td rowspan="1" colspan="1"><bold>T stage</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">T1</td><td rowspan="1" colspan="1">822 (18.0)</td><td rowspan="1" colspan="1">302 (18.3)</td><td rowspan="1" colspan="1">161 (18.7)</td><td rowspan="1" colspan="1">190 (17.7)</td><td rowspan="1" colspan="1">169 (17.1)</td><td rowspan="1" colspan="1">1 (0.5)</td><td rowspan="1" colspan="1">1 (2.2)</td><td rowspan="1" colspan="1">0 (0.0)</td><td rowspan="1" colspan="1">0 (0.0)</td><td rowspan="1" colspan="1">0 (0.0)</td></tr><tr><td rowspan="1" colspan="1">T2</td><td rowspan="1" colspan="1">200 (4.4)</td><td rowspan="1" colspan="1">51 (3.1)</td><td rowspan="1" colspan="1">35 (4.1)</td><td rowspan="1" colspan="1">45 (4.2)</td><td rowspan="1" colspan="1">69 (7.0)</td><td rowspan="1" colspan="1">3 (1.4)</td><td rowspan="1" colspan="1">0 (0.0)</td><td rowspan="1" colspan="1">1 (2.1)</td><td rowspan="1" colspan="1">0 (0.0)</td><td rowspan="1" colspan="1">2 (3.5)</td></tr><tr><td rowspan="1" colspan="1">T3</td><td rowspan="1" colspan="1">742 (16.2)</td><td rowspan="1" colspan="1">205 (12.4)</td><td rowspan="1" colspan="1">141 (16.3)</td><td rowspan="1" colspan="1">191 (17.8)</td><td rowspan="1" colspan="1">205 (20.7)</td><td rowspan="1" colspan="1">24 (10.9)</td><td rowspan="1" colspan="1">4 (8.9)</td><td rowspan="1" colspan="1">2 (4.2)</td><td rowspan="1" colspan="1">10 (14.3)</td><td rowspan="1" colspan="1">8 (14.0)</td></tr><tr><td rowspan="1" colspan="1">T4</td><td rowspan="1" colspan="1">1004 (21.9)</td><td rowspan="1" colspan="1">354 (21.5)</td><td rowspan="1" colspan="1">192 (22.2)</td><td rowspan="1" colspan="1">249 (23.2)</td><td rowspan="1" colspan="1">209 (21.1)</td><td rowspan="1" colspan="1">49 (22.3)</td><td rowspan="1" colspan="1">5 (11.1)</td><td rowspan="1" colspan="1">6 (12.5)</td><td rowspan="1" colspan="1">13 (18.6)</td><td rowspan="1" colspan="1">25 (43.9)</td></tr><tr><td rowspan="1" colspan="1">Unknown</td><td rowspan="1" colspan="1">1807 (39.5)</td><td rowspan="1" colspan="1">735 (44.6)</td><td rowspan="1" colspan="1">334 (38.7)</td><td rowspan="1" colspan="1">400 (37.2)</td><td rowspan="1" colspan="1">338 (34.1)</td><td rowspan="1" colspan="1">143 (65.0)</td><td rowspan="1" colspan="1">35 (77.8)</td><td rowspan="1" colspan="1">39 (81.3)</td><td rowspan="1" colspan="1">47 (67.1)</td><td rowspan="1" colspan="1">22 (38.6)</td></tr><tr><td rowspan="1" colspan="1"><bold>N stage</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">N0</td><td rowspan="1" colspan="1">1542 (33.7)</td><td rowspan="1" colspan="1">613 (37.2)</td><td rowspan="1" colspan="1">294 (34.1)</td><td rowspan="1" colspan="1">321 (29.9)</td><td rowspan="1" colspan="1">314 (31.7)</td><td rowspan="1" colspan="1">4 (1.8)</td><td rowspan="1" colspan="1">1 (2.2)</td><td rowspan="1" colspan="1">1 (2.1)</td><td rowspan="1" colspan="1">0 (0.0)</td><td rowspan="1" colspan="1">2 (3.5)</td></tr><tr><td rowspan="1" colspan="1">N1</td><td rowspan="1" colspan="1">1708 (37.3)</td><td rowspan="1" colspan="1">545 (33.1)</td><td rowspan="1" colspan="1">333 (38.6)</td><td rowspan="1" colspan="1">449 (41.8)</td><td rowspan="1" colspan="1">381 (38.5)</td><td rowspan="1" colspan="1">5 (2.3)</td><td rowspan="1" colspan="1">0 (0.0)</td><td rowspan="1" colspan="1">0 (0.0)</td><td rowspan="1" colspan="1">2 (2.9)</td><td rowspan="1" colspan="1">3 (5.3)</td></tr><tr><td rowspan="1" colspan="1">N2</td><td rowspan="1" colspan="1">301 (6.6)</td><td rowspan="1" colspan="1">72 (4.4)</td><td rowspan="1" colspan="1">51 (5.9)</td><td rowspan="1" colspan="1">75 (7.0)</td><td rowspan="1" colspan="1">103 (10.4)</td><td rowspan="1" colspan="1">23 (10.5)</td><td rowspan="1" colspan="1">3 (6.7)</td><td rowspan="1" colspan="1">0 (0.0)</td><td rowspan="1" colspan="1">12 (17.1)</td><td rowspan="1" colspan="1">8 (14.0)</td></tr><tr><td rowspan="1" colspan="1">N3</td><td rowspan="1" colspan="1">305 (6.7)</td><td rowspan="1" colspan="1">79 (4.8)</td><td rowspan="1" colspan="1">60 (7.0)</td><td rowspan="1" colspan="1">79 (7.3)</td><td rowspan="1" colspan="1">87 (8.8)</td><td rowspan="1" colspan="1">32 (14.5)</td><td rowspan="1" colspan="1">2 (4.4)</td><td rowspan="1" colspan="1">7 (14.6)</td><td rowspan="1" colspan="1">6 (8.6)</td><td rowspan="1" colspan="1">17 (29.8)</td></tr><tr><td rowspan="1" colspan="1">Unknown</td><td rowspan="1" colspan="1">719 (15.7)</td><td rowspan="1" colspan="1">338 (20.5)</td><td rowspan="1" colspan="1">125 (14.5)</td><td rowspan="1" colspan="1">151 (14.0)</td><td rowspan="1" colspan="1">105 (10.6)</td><td rowspan="1" colspan="1">156 (70.9)</td><td rowspan="1" colspan="1">39 (86.7)</td><td rowspan="1" colspan="1">40 (83.3)</td><td rowspan="1" colspan="1">50 (71.4)</td><td rowspan="1" colspan="1">27 (47.4)</td></tr><tr><td rowspan="1" colspan="1"><bold>Surgery</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">470 (10.3)</td><td rowspan="1" colspan="1">99 (6.0)</td><td rowspan="1" colspan="1">68 (7.9)</td><td rowspan="1" colspan="1">125 (11.6)</td><td rowspan="1" colspan="1">178 (18.0)</td><td rowspan="1" colspan="1">0 (0.0)</td><td rowspan="1" colspan="1">0 (0.0)</td><td rowspan="1" colspan="1">0 (0.0)</td><td rowspan="1" colspan="1">0 (0.0)</td><td rowspan="1" colspan="1">0 (0.0)</td></tr><tr><td rowspan="1" colspan="1">No/unknown</td><td rowspan="1" colspan="1">4105 (89.7)</td><td rowspan="1" colspan="1">1548 (94.0)</td><td rowspan="1" colspan="1">795 (92.1)</td><td rowspan="1" colspan="1">950 (88.4)</td><td rowspan="1" colspan="1">812 (82.0)</td><td rowspan="1" colspan="1">220 (100.0)</td><td rowspan="1" colspan="1">45 (100.0)</td><td rowspan="1" colspan="1">48 (100.0)</td><td rowspan="1" colspan="1">70 (100.0)</td><td rowspan="1" colspan="1">57 (100.0)</td></tr><tr><td rowspan="1" colspan="1"><bold>Radiation</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">896 (19.6)</td><td rowspan="1" colspan="1">289 (17.5)</td><td rowspan="1" colspan="1">167 (19.4)</td><td rowspan="1" colspan="1">226 (21.0)</td><td rowspan="1" colspan="1">214 (21.6)</td><td rowspan="1" colspan="1">14 (6.4)</td><td rowspan="1" colspan="1">0 (0.0)</td><td rowspan="1" colspan="1">1 (2.1)</td><td rowspan="1" colspan="1">7 (10.0)</td><td rowspan="1" colspan="1">6 (10.5)</td></tr><tr><td rowspan="1" colspan="1">No/unknown</td><td rowspan="1" colspan="1">3679 (80.4)</td><td rowspan="1" colspan="1">1358 (82.5)</td><td rowspan="1" colspan="1">696 (80.6)</td><td rowspan="1" colspan="1">849 (79.0)</td><td rowspan="1" colspan="1">776 (78.4)</td><td rowspan="1" colspan="1">206 (93.6)</td><td rowspan="1" colspan="1">45 (100.0)</td><td rowspan="1" colspan="1">47 (97.9)</td><td rowspan="1" colspan="1">63 (90.0)</td><td rowspan="1" colspan="1">51 (89.5)</td></tr><tr><td rowspan="1" colspan="1"><bold>Chemotherapy</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">3096 (67.6)</td><td rowspan="1" colspan="1">639 (38.8)</td><td rowspan="1" colspan="1">640 (74.2)</td><td rowspan="1" colspan="1">923 (85.9)</td><td rowspan="1" colspan="1">892 (90.1)</td><td rowspan="1" colspan="1">159 (72.3)</td><td rowspan="1" colspan="1">15 (33.3)</td><td rowspan="1" colspan="1">41 (85.4)</td><td rowspan="1" colspan="1">56 (80.0)</td><td rowspan="1" colspan="1">47 (82.5)</td></tr><tr><td rowspan="1" colspan="1">No/unknown</td><td rowspan="1" colspan="1">1481 (32.4)</td><td rowspan="1" colspan="1">1008 (61.2)</td><td rowspan="1" colspan="1">223 (25.8)</td><td rowspan="1" colspan="1">152 (14.1)</td><td rowspan="1" colspan="1">98 (9.9)</td><td rowspan="1" colspan="1">61 (27.7)</td><td rowspan="1" colspan="1">30 (66.7)</td><td rowspan="1" colspan="1">7 (14.6)</td><td rowspan="1" colspan="1">14 (20.0)</td><td rowspan="1" colspan="1">10 (17.5)</td></tr><tr><td rowspan="1" colspan="1"><bold>Cause of death</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Gastric cancer</td><td rowspan="1" colspan="1">4434 (96.9)</td><td rowspan="1" colspan="1">1588 (96.4)</td><td rowspan="1" colspan="1">842 (97.6)</td><td rowspan="1" colspan="1">1044 (97.1)</td><td rowspan="1" colspan="1">960 (97.0)</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td></tr><tr><td rowspan="1" colspan="1">Other causes</td><td rowspan="1" colspan="1">141 (3.1)</td><td rowspan="1" colspan="1">59 (3.6)</td><td rowspan="1" colspan="1">21 (2.4)</td><td rowspan="1" colspan="1">31 (2.9)</td><td rowspan="1" colspan="1">30 (3.0)</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td><td rowspan="1" colspan="1">NA</td></tr></tbody></table><table-wrap-foot><fn><p>Abbreviations: not available, NA.</p></fn></table-wrap-foot></table-wrap><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>Univariate and multivariate logistic regression for analyzing the risk factors for early death in the SEER database</p></caption><table frame="hsides" rules="groups"><thead valign="top"><tr><th rowspan="2" colspan="1">Variables</th><th colspan="3" rowspan="1">Univariate</th><th colspan="3" rowspan="1">Multivariate</th></tr><tr><th rowspan="1" colspan="1">OR</th><th rowspan="1" colspan="1">95%CI</th><th rowspan="1" colspan="1"><italic>p</italic> value</th><th rowspan="1" colspan="1">OR</th><th rowspan="1" colspan="1">95%CI</th><th rowspan="1" colspan="1"><italic>p</italic> value</th></tr></thead><tbody valign="top"><tr><td rowspan="1" colspan="1"><bold>Age (years)</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">&#x0003c;40</td><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">40-59</td><td rowspan="1" colspan="1">1.087</td><td rowspan="1" colspan="1">0.815-1.463</td><td rowspan="1" colspan="1">0.575</td><td rowspan="1" colspan="1">0.836</td><td rowspan="1" colspan="1">0.603-1.168</td><td rowspan="1" colspan="1">0.286</td></tr><tr><td rowspan="1" colspan="1">60-79</td><td rowspan="1" colspan="1">1.513</td><td rowspan="1" colspan="1">1.143-2.023</td><td rowspan="1" colspan="1"><bold>0.004</bold></td><td rowspan="1" colspan="1">1.106</td><td rowspan="1" colspan="1">0.799-1.545</td><td rowspan="1" colspan="1">0.548</td></tr><tr><td rowspan="1" colspan="1">80+</td><td rowspan="1" colspan="1">3.496</td><td rowspan="1" colspan="1">2.549-4.836</td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td><td rowspan="1" colspan="1">1.458</td><td rowspan="1" colspan="1">0.993-2.152</td><td rowspan="1" colspan="1">0.056</td></tr><tr><td rowspan="1" colspan="1"><bold>Sex</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Male</td><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Female</td><td rowspan="1" colspan="1">1.021</td><td rowspan="1" colspan="1">0.899-1.159</td><td rowspan="1" colspan="1">0.748</td><td rowspan="1" colspan="1">0.828</td><td rowspan="1" colspan="1">0.704-0.973</td><td rowspan="1" colspan="1">0.022</td></tr><tr><td rowspan="1" colspan="1"><bold>Race</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">White</td><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Black</td><td rowspan="1" colspan="1">1.091</td><td rowspan="1" colspan="1">0.906-1.311</td><td rowspan="1" colspan="1">0.356</td><td rowspan="1" colspan="1">0.910</td><td rowspan="1" colspan="1">0.727-1.137</td><td rowspan="1" colspan="1">0.410</td></tr><tr><td rowspan="1" colspan="1">Other</td><td rowspan="1" colspan="1">0.834</td><td rowspan="1" colspan="1">0.695-0.998</td><td rowspan="1" colspan="1">0.049</td><td rowspan="1" colspan="1">0.706</td><td rowspan="1" colspan="1">0.569-0.874</td><td rowspan="1" colspan="1"><bold>0.001</bold></td></tr><tr><td rowspan="1" colspan="1"><bold>Marital status</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Married</td><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Separated/Divorced</td><td rowspan="1" colspan="1">0.049</td><td rowspan="1" colspan="1">1.090-1.623</td><td rowspan="1" colspan="1"><bold>0.005</bold></td><td rowspan="1" colspan="1">1.305</td><td rowspan="1" colspan="1">1.034-1.642</td><td rowspan="1" colspan="1">0.024</td></tr><tr><td rowspan="1" colspan="1">Widowed</td><td rowspan="1" colspan="1">2.243</td><td rowspan="1" colspan="1">1.842-2.732</td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td><td rowspan="1" colspan="1">1.241</td><td rowspan="1" colspan="1">0.963-1.598</td><td rowspan="1" colspan="1">0.094</td></tr><tr><td rowspan="1" colspan="1">Single</td><td rowspan="1" colspan="1">1.405</td><td rowspan="1" colspan="1">1.195-1.651</td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td><td rowspan="1" colspan="1">1.273</td><td rowspan="1" colspan="1">1.047-1.547</td><td rowspan="1" colspan="1">0.015</td></tr><tr><td rowspan="1" colspan="1"><bold>Primary site</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Cardiac/fundus</td><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Body</td><td rowspan="1" colspan="1">1.103</td><td rowspan="1" colspan="1">0.888-1.367</td><td rowspan="1" colspan="1">0.371</td><td rowspan="1" colspan="1">1.201</td><td rowspan="1" colspan="1">0.921-1.561</td><td rowspan="1" colspan="1">0.174</td></tr><tr><td rowspan="1" colspan="1">Antrum/pylorus</td><td rowspan="1" colspan="1">1.308</td><td rowspan="1" colspan="1">1.091-1.565</td><td rowspan="1" colspan="1"><bold>0.004</bold></td><td rowspan="1" colspan="1">1.305</td><td rowspan="1" colspan="1">1.036-1.644</td><td rowspan="1" colspan="1">0.023</td></tr><tr><td rowspan="1" colspan="1">Lesser&#x00026; greater curvature</td><td rowspan="1" colspan="1">1.184</td><td rowspan="1" colspan="1">0.999-1.401</td><td rowspan="1" colspan="1">0.051</td><td rowspan="1" colspan="1">1.314</td><td rowspan="1" colspan="1">1.064-1.620</td><td rowspan="1" colspan="1">0.011</td></tr><tr><td rowspan="1" colspan="1">Other</td><td rowspan="1" colspan="1">1.464</td><td rowspan="1" colspan="1">1.222-1.752</td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td><td rowspan="1" colspan="1">1.148</td><td rowspan="1" colspan="1">0.919-1.435</td><td rowspan="1" colspan="1">0.223</td></tr><tr><td rowspan="1" colspan="1"><bold>Histology</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Adenocarcinoma</td><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Signet ring cell carcinoma</td><td rowspan="1" colspan="1">0.893</td><td rowspan="1" colspan="1">0.778-1.024</td><td rowspan="1" colspan="1">0.107</td><td rowspan="1" colspan="1">0.999</td><td rowspan="1" colspan="1">0.831-1.201</td><td rowspan="1" colspan="1">0.996</td></tr><tr><td rowspan="1" colspan="1"><bold>Grade</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Well/moderately</td><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Poorly /undifferentiated</td><td rowspan="1" colspan="1">1.321</td><td rowspan="1" colspan="1">1.144-1.528</td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td><td rowspan="1" colspan="1">1.904</td><td rowspan="1" colspan="1">1.588-2.287</td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td></tr><tr><td rowspan="1" colspan="1"><bold>Bone metastases</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">No/unknown</td><td rowspan="1" colspan="1">0.752</td><td rowspan="1" colspan="1">0.632-0.895</td><td rowspan="1" colspan="1"><bold>0.001</bold></td><td rowspan="1" colspan="1">0.64</td><td rowspan="1" colspan="1">0.521-0.786</td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td></tr><tr><td rowspan="1" colspan="1"><bold>Brain metastases</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">No/unknown</td><td rowspan="1" colspan="1">0.401</td><td rowspan="1" colspan="1">0.264-0.603</td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td><td rowspan="1" colspan="1">0.328</td><td rowspan="1" colspan="1">0.202-0.529</td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td></tr><tr><td rowspan="1" colspan="1"><bold>Liver metastases</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">No/unknown</td><td rowspan="1" colspan="1">0.815</td><td rowspan="1" colspan="1">0.722-0.921</td><td rowspan="1" colspan="1"><bold>0.001</bold></td><td rowspan="1" colspan="1">0.798</td><td rowspan="1" colspan="1">0.682-0.934</td><td rowspan="1" colspan="1"><bold>0.005</bold></td></tr><tr><td rowspan="1" colspan="1"><bold>Lung metastases</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">No/unknown</td><td rowspan="1" colspan="1">0.746</td><td rowspan="1" colspan="1">0.631-0.884</td><td rowspan="1" colspan="1"><bold>0.001</bold></td><td rowspan="1" colspan="1">0.749</td><td rowspan="1" colspan="1">0.614-0.915</td><td rowspan="1" colspan="1"><bold>0.004</bold></td></tr><tr><td rowspan="1" colspan="1"><bold>T stage</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">T1</td><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">T2</td><td rowspan="1" colspan="1">0.589</td><td rowspan="1" colspan="1">0.413-0.830</td><td rowspan="1" colspan="1"><bold>0.003</bold></td><td rowspan="1" colspan="1">0.591</td><td rowspan="1" colspan="1">0.391-0.883</td><td rowspan="1" colspan="1">0.011</td></tr><tr><td rowspan="1" colspan="1">T3</td><td rowspan="1" colspan="1">0.657</td><td rowspan="1" colspan="1">0.530-0.814</td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td><td rowspan="1" colspan="1">0.928</td><td rowspan="1" colspan="1">0.719-1.197</td><td rowspan="1" colspan="1">0.566</td></tr><tr><td rowspan="1" colspan="1">T4</td><td rowspan="1" colspan="1">0.938</td><td rowspan="1" colspan="1">0.774-1.136</td><td rowspan="1" colspan="1">0.512</td><td rowspan="1" colspan="1">1.121</td><td rowspan="1" colspan="1">0.887-1.418</td><td rowspan="1" colspan="1">0.341</td></tr><tr><td rowspan="1" colspan="1">Unknown</td><td rowspan="1" colspan="1">1.181</td><td rowspan="1" colspan="1">0.996-1.400</td><td rowspan="1" colspan="1">0.056</td><td rowspan="1" colspan="1">1.051</td><td rowspan="1" colspan="1">0.858-1.289</td><td rowspan="1" colspan="1">0.630</td></tr><tr><td rowspan="1" colspan="1"><bold>N stage</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">N0</td><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">N1</td><td rowspan="1" colspan="1">0.710</td><td rowspan="1" colspan="1">0.615-0.820</td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td><td rowspan="1" colspan="1">0.821</td><td rowspan="1" colspan="1">0.692-0.973</td><td rowspan="1" colspan="1">0.023</td></tr><tr><td rowspan="1" colspan="1">N2</td><td rowspan="1" colspan="1">0.476</td><td rowspan="1" colspan="1">0.357-0.630</td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td><td rowspan="1" colspan="1">0.703</td><td rowspan="1" colspan="1">0.500-0.982</td><td rowspan="1" colspan="1">0.041</td></tr><tr><td rowspan="1" colspan="1">N3</td><td rowspan="1" colspan="1">0.530</td><td rowspan="1" colspan="1">0.400-0.695</td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td><td rowspan="1" colspan="1">0.783</td><td rowspan="1" colspan="1">0.553-1.102</td><td rowspan="1" colspan="1">0.164</td></tr><tr><td rowspan="1" colspan="1">Unknown</td><td rowspan="1" colspan="1">1.344</td><td rowspan="1" colspan="1">1.125-1.607</td><td rowspan="1" colspan="1"><bold>0.001</bold></td><td rowspan="1" colspan="1">1.245</td><td rowspan="1" colspan="1">1.005-1.542</td><td rowspan="1" colspan="1">0.045</td></tr><tr><td rowspan="1" colspan="1"><bold>Surgery</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">No/unknown</td><td rowspan="1" colspan="1">2.269</td><td rowspan="1" colspan="1">1.809-2.870</td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td><td rowspan="1" colspan="1">2.697</td><td rowspan="1" colspan="1">1.993-3.675</td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td></tr><tr><td rowspan="1" colspan="1"><bold>Radiation</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">No/unknown</td><td rowspan="1" colspan="1">1.229</td><td rowspan="1" colspan="1">1.053-1.437</td><td rowspan="1" colspan="1"><bold>0.009</bold></td><td rowspan="1" colspan="1">0.985</td><td rowspan="1" colspan="1">0.815-1.193</td><td rowspan="1" colspan="1">0.879</td></tr><tr><td rowspan="1" colspan="1"><bold>Chemotherapy</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Yes</td><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Ref</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">No/unknown</td><td rowspan="1" colspan="1">8.187</td><td rowspan="1" colspan="1">7.125-9.422</td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td><td rowspan="1" colspan="1">8.53</td><td rowspan="1" colspan="1">7.308-9.978</td><td rowspan="1" colspan="1"><bold>&#x0003c;0.001</bold></td></tr></tbody></table></table-wrap></floats-group></article>